NexImmune Inc Ordinary Shares NEXI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–2.17
- Bid/Ask
- $0.03 / $0.15
- Shares Outstanding
- 1.39M
- Market Cap
- $139.47
- Volume/Avg
- 1,486 / 567
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
NexImmune Inc is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s T cells to generate an antigen-specific cell-mediated immune response with curative potential for the patient. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. The company has two product candidates in human trials: NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 50
- Website
- https://www.neximmune.com
Valuation
Metric | NEXI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | NEXI |
|---|---|
Quick Ratio | 0.51 |
Current Ratio | 0.66 |
Interest Coverage | — |
Quick Ratio
NEXI
Profitability
Metric | NEXI |
|---|---|
Return on Assets (Normalized) | −130.58% |
Return on Equity (Normalized) | −249.29% |
Return on Invested Capital (Normalized) | −239.23% |
Return on Assets
NEXI
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|>JwkD% | LOCK|#tnHR | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|N#VSvT | LOCK|#n$F | $95B | |||
| Moderna Inc MRNA | LOCK|S$J<>^z | LOCK|<>M | $79B | |||
| argenx SE ADR ARGX | LOCK|DjnY$# | LOCK|>j% | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|pSn?$rR | LOCK|!x$ | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|N%Y?!lP | LOCK|sb&q | $30B | |||
| Incyte Corp INCY | LOCK|jL@ql$$ | LOCK|fH< | $23B | |||
| BioNTech SE ADR BNTX | LOCK|pyq@#sR | LOCK|&yL | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|KTnnLV! | LOCK|PFW$< | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|SkCjCTb | LOCK|BH? | $15B |